Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>

2018344 citationsJournal Articlegreen Open Access

Authors

CAZ-AVI appears to be a promising drug for treatment of severe KPC-Kp infections, especially those involving bacteremia.

Good health and well-being

Published in: Clinical Infectious Diseases

Volume 68, Issue 3, pp. 355-364

Field-Weighted Citation Impact: 12.74